← Back
$IPSC All transactions

Century Therapeutics, Inc.

A

$ Value

$0

Shares

135,000

Price

$0

Filed

Feb 4

Insider

Name

Cowan Chad

Title

Chief Scientific Officer

CIK

0002039294

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,178,476

Footnotes

Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on February 2, 2027, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. | Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. | The option vests 25% on February 2, 2027, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Filing Info

Accession No.

0002039294-26-000004

Form Type

4

Issuer CIK

0001850119

Cowan Chad's History

Date Ticker Type Value
2026-04-01 IPSC F $3K
2026-03-11 IPSC F $4K
2026-02-02 IPSC A $0
2026-02-02 IPSC A $0
2026-01-02 IPSC F $2K
2025-12-22 IPSC $49K
2025-11-20 IPSC $3K
2025-09-18 IPSC A $0

Other Insiders at IPSC (90d)

Insider Bought Sold Last
Carr Douglas
SVP Finance & Operations
$19K 2026-03-12
Russotti Gregory
See Remarks
$27K 2026-03-12
Pfeiffenberger Brent
President and CEO
2026-03-11
Cowan Chad
Chief Scientific Officer
2026-04-01
Murphy Martin Patrick 2025-12-09